Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Advanced Bladder Cancer × enfortumab vedotin × Clear all

Phase

Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 5 Carcinoma, Transitional Cell 5 Urologic Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Advanced Solid Tumor 1 Advanced Bladder Cancer 1

Interventions

enfortumab vedotin 1 Radiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06434350 2026-03-02

Enfortumab Vedotin With Radiation for Locally Advanced Bladder Cancer (CONSOLIDATE)

M.D. Anderson Cancer Center

Phase 1/2 Recruiting

Advanced Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡